EPRAM Stock Overview
Amundi Index Solutions - Amundi Index FTSE EPRA NAREIT Global UCITS ETF DR is an exchange traded fund launched by Amundi Luxembourg S.A.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Amundi Index Solutions - Amundi Index FTSE EPRA NAREIT Global UCITS ETF DR Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €58.88 |
| 52 Week High | €58.89 |
| 52 Week Low | €57.82 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -1.35% |
| Change since IPO | 23.79% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| EPRAM | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | 2.7% |
| 1Y | n/a | 10.5% | 5.2% |
Return vs Industry: Insufficient data to determine how EPRAM performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how EPRAM performed against the UK Market.
Price Volatility
| EPRAM volatility | |
|---|---|
| EPRAM Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: EPRAM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EPRAM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | n/a | www.amundietf.lu/professional/product/view/LU1437018838 |
Amundi Index Solutions - Amundi Index FTSE EPRA NAREIT Global UCITS ETF DR is an exchange traded fund launched by Amundi Luxembourg S.A. It is managed by Amundi Asset Management. The fund invests in public equity markets across the globe.
Amundi Index Solutions - Amundi Index FTSE EPRA NAREIT Global UCITS ETF DR Fundamentals Summary
| EPRAM fundamental statistics | |
|---|---|
| Market cap | n/a |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs EPRAM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPRAM income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EPRAM perform over the long term?
See historical performance and comparison